LONDON (Reuters) - GlaxoSmithKline’s incoming chief executive said on Wednesday he would make emerging markets a priority for future growth by creating a new region targeting such countries.

Andrew Witty, who takes over at the head of world’s biggest drugmaker by sales next month, said emerging markets were already contributing close to 25 percent of current market growth and were forecast to grow even faster in the future.

A new Asia Pacific region will also be created, which includes Japan and Australia.

(Reporting by Ben Hirschler)